Prolonged Dual Antiplatelet Therapy in Acute Myocardial Infarction Patients Without Revascularization: China Acute Myocardial Infarction Registry Study

At least 12 months of dual antiplatelet therapy (DAPT) is 1 of the standards of care following percutaneous coronary intervention in patients with acute coronary syndrome. However, study on prolonged DAPT for patients with acute myocardial infarction (AMI) without revascularization is limited. We st...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2024-04, Vol.217, p.39-48
Hauptverfasser:	Huang, Cunrong, Yang, Jingang, Li, Ling, He, Shenghu, Zhang, Xuxia, Xu, Haiyan, Wu, Yuan, Zhang, Jun, Qiao, Shubin, Wu, Yongjian, Zhao, Yanyan, Wang, Yang, Li, Wei, Jin, Chen, Gao, Xiaojin, Yang, Yuejin
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute coronary syndromes all-cause mortality Antiplatelet therapy Bleeding Cardiology Cerebral infarction Chi-square test Clinical outcomes Death Diabetes dual antiplatelet therapy Enzymes Heart attacks Hypertension Ischemia Mortality Myocardial infarction nonrevascularization Statistical analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	At least 12 months of dual antiplatelet therapy (DAPT) is 1 of the standards of care following percutaneous coronary intervention in patients with acute coronary syndrome. However, study on prolonged DAPT for patients with acute myocardial infarction (AMI) without revascularization is limited. We studied 1,744 patients with AMI without revascularization from the China Acute Myocardial Infarction registry between January 2013 and September 2014. These patients were on DAPT and did not experience AMI, stroke, or bleeding events at the 12-month follow-up. We divided them into 2 groups: 12-month DAPT group (DAPT for at least 12 months but
ISSN:	0002-9149 1879-1913 1879-1913
DOI:	10.1016/j.amjcard.2024.02.010